Healthcare
Thursday, June 23, 2016
BRIEF-Immunovaccine awarded subcontract to evaluate depovax for development of malaria vaccine targets
* Awarded a subcontract by leidos to evaluate
immunovaccine's depovax(tm) platform for development of peptide
based malaria vaccine targets
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment